GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APP, AXL, CA2, CA9, CES1, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP1, TYR |
11.3716 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.1761 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, FUT7, HTR2B, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
10.6058 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, CDC25B, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, SLC6A4, SRC, TERT, XDH |
10.3907 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA, PTGS1, PTGS2 |
10.3837 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.3837 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
9.38867 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
9.14487 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
9.12279 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, PPARA, PTGS2, RORC, SLC6A4, SRC, TYR |
9.12279 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
8.98986 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
8.97071 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
8.97071 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, ESR1, HSD17B1, HSD17B2 |
8.81679 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
8.51689 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HTR5A, IGF1R, KDR, MMP2, PPARA, PTGS2, RORC, SLC6A4, SRC, TYR |
8.50183 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KCNH2, KDR, MET, PPARA, PTGS1, PTGS2, SLC6A2, SLC6A4, SRC, TERT, XDH |
8.4334 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HTR5A, PTGS2, RORC, SLC6A4, SRC, TYR |
8.11311 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TOP1, TYR |
8.06252 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
7.93376 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA6, CA9, CES1, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP1, TYR |
7.86037 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TOP1, TYR, XDH |
7.84618 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
7.83169 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, PTGS1, RORC |
7.67853 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
7.67853 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
7.67853 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CXCL8, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HTR5A, IGF1R, MMP2, PPARA, PTGS2, SLC6A4, SRC |
7.61652 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, HTR5A, PTGS2, RORC, SLC6A4, SRC, TYR |
7.41256 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.38506 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.38506 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNH2, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TOP1 |
7.29715 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TOP1, TYR, XDH |
7.27825 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.14078 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.11655 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
7.07714 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, FABP3, FABP4, FUT7, MET, PPARA, PTGS1, PTGS2 |
7.04004 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
6.92468 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, CDC25B, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
6.87132 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.75826 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.75826 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
6.70624 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
6.70117 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
6.61536 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
6.58823 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
6.51524 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APP, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
6.50994 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, ADRA2A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HTR5A, PPARA, PTGS2, SLC6A4, SRC |
6.43081 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
6.34025 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
6.2958 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
6.26607 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTGS2, PTPN1, SRC, XDH |
6.26607 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
6.12038 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, PTGS2, RORC, SRC |
6.10678 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
6.01021 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
6.01021 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
5.97581 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
5.96285 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2, SLC6A4 |
5.96073 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
5.88924 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGS2, SRC, TERT |
5.86087 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A, PTGS2, SLC6A4 |
5.72047 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, KDR, PTGS2, SRC |
5.71732 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
5.68523 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
5.68195 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.68195 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.68195 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
5.51147 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.45783 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
5.38785 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AXL, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, PTGS2, RORC, SLC6A4, SRC, TERT |
5.38684 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A |
5.38684 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD17B1, HSD17B2, PTGS1, PTGS2, TYR, XDH |
5.38535 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, KCNH2, MET, SRC, TERT |
5.3847 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, ESR1, HTR7, PPARA, RORC, SLC6A4, SRC, TOP1 |
5.31326 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.26738 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CES1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SIGMAR1, SLC6A4, SRC, TERT, TYR |
5.23373 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, CXCL8, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
5.22793 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, PTGS2 |
5.15433 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, CXCL8, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
5.14754 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, CXCL8, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
5.12808 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.08866 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.07305 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, CXCL8, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
5.07305 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNH2, PPARA, SLC6A2, SLC6A4 |
5.05698 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SLC6A2, SLC6A4, SRC, TERT, TOP1, TYR, XDH |
5.05698 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.01264 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR2B, KCNH2, MMP12, PTGS2, SLC6A4, SRC, TERT |
4.97723 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, CXCL8, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
4.95585 |
[BP] GO:0007200 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, ESR1, HTR2A, HTR2B |
4.9176 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CES1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, SLC6A4, SRC |
4.80477 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, CXCL8, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
4.79065 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT, TYR |
4.73562 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SIGMAR1, SRC, TERT, XDH |
4.70596 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, DRD2, DRD3, HTR2A, KCNH2, MMP9, PTGS2 |
4.70596 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
4.68598 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SIGMAR1, SRC, TERT, XDH |
4.63663 |
[BP] GO:0045744 |
None
|
ADRA2A, CXCL8, DRD2, DRD3, MET |
4.58378 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRA2A, APP, AXL, CA2, CXCL8, CYP1B1, DRD2, DRD3, ESRRB, F3, HCAR2, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT |
4.5767 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR1A, HTR2A, KCNH2, MMP9, PTGS2, SLC6A4 |
4.55158 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.5206 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, CA2, CXCL8, DRD1, DRD2, DRD3, ESR1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
4.50825 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC |
4.50387 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.49879 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3 |
4.44418 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.42096 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, ADRA2A, AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, KCNH2, MET |
4.42096 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.40225 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
4.39972 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.34037 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.25695 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.24815 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APP, AXL, CXCL8, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PTGS2, RORC, SLC6A4, SRC |
4.24815 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
4.20399 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
4.20399 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRA2A, CXCL8, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
4.12414 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SIGMAR1, SRC, TERT, XDH |
4.12066 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.06299 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.06299 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, HTR2A |
4.01447 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, PTGS2, SRC |
3.98886 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
3.95262 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.9448 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
3.9441 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.93604 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.92918 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.9041 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, PTGS2, SLC6A2, SLC6A4 |
3.86507 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.85223 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, APP, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.82072 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
3.8165 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.8133 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.80935 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
3.79646 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6 |
3.78986 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.77029 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.76381 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.76375 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
3.75409 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC, SLC6A4, TOP1 |
3.75409 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CA1, CA2, CSNK2A1, CXCL8, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC |
3.74054 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
3.74054 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.73077 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, CA2, CXCL8, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HCAR2, HTR2A, HTR2B, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SLC6A4, SRC, TERT, XDH |
3.69232 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.68433 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, CXCL8, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.66075 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.62955 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.60798 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.58711 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CXCL8, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, PTGS2, RORC, SLC6A4, SRC |
3.58532 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HTR5A, KDR, MMP9, PIM1, PPARA, PTGS2, RORC, SIGMAR1, SRC, TYR |
3.58532 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
3.57543 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
3.5675 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, SRC, XDH |
3.55304 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SLC6A4, SRC, TYR |
3.55213 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.54114 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, PPARA, PTGS1, PTGS2 |
3.53102 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
3.52128 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AURKB, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
3.506 |
[BP] GO:0031623 |
None
|
ACHE, CXCL8, DRD2, DRD3, HTR2B |
3.48445 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC, TOP1 |
3.48445 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
3.48141 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, HTR2A, KCNH2 |
3.47945 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
3.45441 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B, KCNH2 |
3.45331 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.43435 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CXCL8, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA, PTGS2 |
3.4272 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.42567 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.42567 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT |
3.42263 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, SLC6A4, SRC |
3.41416 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
3.37633 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, PTGS2 |
3.37277 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A, PTGS2 |
3.35987 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
3.35442 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, CXCL8, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
3.30935 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
3.28708 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.27027 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.25103 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TOP1 |
3.24044 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SLC6A4, SRC, TYR |
3.22241 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2, TERT |
3.20084 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
3.19066 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, APP, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
3.16185 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.14013 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
3.08563 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
3.06494 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.06418 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
3.03782 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.03782 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, PPARA, PTGS2, RORC, SRC, TERT |
3.03573 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
3.01241 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.009 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, CYP1B1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR7, KCNH2, PTGS2, SLC6A4, SRC, TYR |
2.98601 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
2.97489 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3 |
2.97489 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.97489 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, HTR5A, PTGS2, SLC6A4 |
2.95846 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2 |
2.95764 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
2.95107 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.9437 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2 |
2.9343 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ADRA2A, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CXCL8, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PPARA, SIGMAR1, SLC6A2, SLC6A4, SRC, XDH |
2.91606 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA1A, ADRA2A, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CXCL8, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PPARA, SIGMAR1, SLC6A2, SLC6A4, SRC, TERT, XDH |
2.91158 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.91158 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.91158 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.91158 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP1, TYR, XDH |
2.91158 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.88279 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.87152 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA1A, ADRA2A, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CXCL8, DRD1, DRD2, DRD3, ESR1, F10, FABP3, HTR2A, HTR2B, KCNH2, MMP12, MMP9, PPARA, SIGMAR1, SLC6A2, SLC6A4, SRC, TERT, XDH |
2.8645 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
2.8645 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.8645 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.8645 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, SRC |
2.85271 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, PTPN1, SRC |
2.84757 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.82642 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.82642 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.82642 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KCNH2, KDR, PTGS2, SRC |
2.77198 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, SLC6A4, SRC, TERT |
2.76016 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
2.76016 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, CXCL8, DRD1, ESR1, FLT3, IGF1R, MMP2, PTGS2, SLC6A4, SRC |
2.74539 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, DRD2, HTR2A, KCNH2, PTGS2 |
2.74521 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.74101 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.74101 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.74101 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.74101 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9 |
2.74037 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, ADRA2A, CXCL8, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.73977 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.72627 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.71959 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.6991 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.6991 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, DRD2, DRD3, HCAR2, HTR2B, MMP12, PTGS2, PTPN1, SRC |
2.69011 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.68378 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, MET, MMP12, PPARA, PTGS2, RORC, SRC, TERT |
2.68378 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, DRD2, HTR2A, HTR2B, SRC |
2.67205 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2 |
2.67205 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.67205 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.67205 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.67205 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.67205 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, CXCL8, CYP1B1, DRD2, FABP3, PTGS2, SLC6A4, TERT, XDH |
2.6594 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.62393 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIM1, PTGS2, PTPN1, SRC, TOP1, XDH |
2.61463 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, SLC6A4 |
2.60329 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.5953 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.5953 |
[BP] GO:0016477 |
cell migration
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
2.5944 |
[BP] GO:0050433 |
None
|
ADRA2A, DRD2, DRD3, HTR2A |
2.53655 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRA2A, AKR1B1, AXL, CXCL8, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MET, PTPN1, SRC |
2.53655 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TERT |
2.53327 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9 |
2.52331 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.50786 |
[BP] GO:0043112 |
None
|
ACHE, CXCL8, DRD2, DRD3, HTR2B |
2.50661 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, FLT3, HTR2A, PTPN1, SRC |
2.4908 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.47963 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.47963 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.47963 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.47963 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.47963 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, APP, AXL, CXCL8, DRD2, DRD3, HTR2B, SLC6A2, SLC6A4 |
2.46767 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, PPARA |
2.46719 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.46234 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.46234 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
2.46017 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.46017 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2 |
2.45695 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, DRD2, DRD3, HCAR2, HTR2A, KCNH2, PTGS2 |
2.45561 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
2.44868 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9 |
2.42329 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, PPARA |
2.39919 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.39919 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.39841 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIM1, PTGS2, PTPN1, SRC, TOP1, XDH |
2.36828 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.3682 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TOP1 |
2.36267 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRA2A, APP, AURKB, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, MET, MMP9, PTPN1, SRC, TERT, XDH |
2.34477 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.34109 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.34109 |
[BP] GO:0040011 |
locomotion
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, SRC |
2.34059 |
[BP] GO:0007613 |
None
|
DRD1, DRD2, HTR2A, PTGS2, SLC6A4 |
2.33837 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA, PTGS2, SLC6A4 |
2.33213 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.30469 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, HTR2A, PTPN1, SRC |
2.30355 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.28873 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.28873 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.28873 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.28873 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
2.28775 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, SRC, TERT |
2.28775 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TERT |
2.28555 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.27477 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.27164 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PTGS1, PTGS2 |
2.26345 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.25351 |
[BP] GO:0048870 |
cell motility
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
2.24676 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.24041 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.24041 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.24041 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.23939 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.23939 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.23939 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, DRD2, DRD3, HCAR2, HTR2B, MMP12, SRC |
2.23019 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.22761 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HCAR2, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.21425 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A |
2.21304 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, HTR2A, KCNH2, PTGS2 |
2.20964 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2C19, CYP2D6 |
2.20865 |
[BP] GO:0019229 |
None
|
ADRA1A, ADRA2A, HTR2A, PTGS2 |
2.20726 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, PTPN1, SRC |
2.20726 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, HCAR2, HTR2B, MMP12, SLC6A4, SRC |
2.20566 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.20346 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.20346 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.20346 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20346 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.18964 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.18756 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP1, TYR, XDH |
2.18378 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, PTGS2, SLC6A4, SRC |
2.17847 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.17847 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.16429 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.15986 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.15757 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.15757 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.15757 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.14691 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, KCNH2, SLC6A2 |
2.13111 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.13111 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, TERT |
2.12785 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, PTGS2 |
2.12114 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.12114 |
[BP] GO:0050927 |
None
|
CXCL8, F3, KDR |
2.11075 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CXCL8, CYP1A1, CYP1A2, PTGS2, SRC |
2.10289 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.10229 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, MMP12, PPARA, SIGMAR1, SLC6A2, SLC6A4 |
2.10118 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.10118 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, ADRA2A, PTGS2 |
2.10118 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, APP, AXL, CXCL8, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PTGS2, SRC |
2.09912 |
[BP] GO:0050926 |
None
|
CXCL8, F3, KDR |
2.07213 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.07213 |
[BP] GO:0006693 |
None
|
CES2, PTGS1, PTGS2 |
2.07213 |
[BP] GO:0006692 |
None
|
CES2, PTGS1, PTGS2 |
2.07213 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.07213 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07213 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.07213 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.07213 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.07213 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.07213 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.07213 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.06608 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.06608 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B1, HSD17B2 |
2.05378 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B |
2.05128 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, PTGS2, TYR |
2.05128 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.04728 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.04728 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, DRD1, DRD2, DRD3, KCNH2, MMP9 |
2.0366 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.03327 |
[BP] GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway
|
ADRA2A, CXCL8, DRD2, DRD3, MET |
2.03071 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.03071 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR2A, IGF1R, MET, MMP12, PPARA, PTPN1, RORC, SRC, TERT |
2.01872 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.00535 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.00108 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, APP, DRD2, DRD3, HTR2A, KCNH2, MMP9, PTGS2 |
2.00108 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.00108 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.00108 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.00108 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.00108 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, CA4, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC6A2, SLC6A4 |
6.75052 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC6A2, SLC6A4 |
5.15924 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PTGS2, SIGMAR1, SLC6A2, SLC6A4, SRC |
4.74139 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
4.32131 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SRC, TERT, TYR |
3.91274 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, F10, FLT3, HSD17B2, PTGS1, PTGS2, PTPN1, SIGMAR1 |
3.90278 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SRC, TYR |
3.79646 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, APP, HTR2A, KDR, PTGS2, SLC6A2, SLC6A4, SRC |
2.68166 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, HTR5A, KDR, PTGS2, PTPN1, SIGMAR1, XDH |
2.67205 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, APP, HTR2A, KDR, PTGS2, SLC6A2, SLC6A4, SRC |
2.67205 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.34109 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, HSD17B2, PTGS1, PTGS2, SIGMAR1 |
2.24319 |
[CC] GO:0098589 |
membrane region
|
ADRA1A, APP, HTR2A, KDR, PTGS2, SLC6A2, SLC6A4, SRC |
2.21474 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR2A, HTR5A, KCNH2, KDR, MMP2, MMP9, PIM1, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC6A4, SRC, TERT, TOP1, TYR, XDH |
2.05378 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, ADRA2A, CA2, CA4, CA9, DRD1, DRD2, HTR2A, MET, PTGS2, SIGMAR1, SRC |
2.04346 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
17.0157 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.5745 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP1, TYR, XDH |
14.2466 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
12.1856 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.3837 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, SLC6A4 |
9.15489 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1 |
9.1484 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.12279 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRA2A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
8.78621 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC |
8.39661 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1 |
8.17319 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.13023 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC |
8.09726 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1 |
7.93031 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, F10, F3, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, PTPN1, SRC, TERT, TOP1, TYR, XDH |
7.93028 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TYR |
7.67853 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, XDH |
7.54917 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
7.42022 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1 |
7.39287 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
7.10364 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TYR |
7.10364 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.84037 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.76748 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.76748 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.75826 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.75826 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6 |
6.70117 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.67499 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD17B1, HSD17B2, PTGS1, PTGS2, TYR, XDH |
6.62015 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SLC6A4, SRC, TOP1 |
6.10465 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
5.96285 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
5.91238 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD17B1, PTGS1, PTGS2, SRC, XDH |
5.65104 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
5.65104 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
5.31326 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
5.31326 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05473 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05473 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.91292 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.60696 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2, DRD3 |
3.8133 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
3.75409 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
3.57543 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.5675 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
3.37567 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.26218 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.91158 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.8645 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.8645 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.8645 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TOP1, XDH |
2.83825 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.82642 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.82642 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.78165 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
2.77929 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, DRD2, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, PTGS2, SLC6A4, TERT, TYR, XDH |
2.6885 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.63957 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.5953 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.5218 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.5218 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.47963 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.47963 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.34109 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TOP1 |
2.32778 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.28873 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.23939 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.23939 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.22459 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.07213 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.06608 |